Helius Medical Technologies Inc Class A

Yahoo Finance • 3 days ago

Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke

NEWTOWN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510(k) submission for the PoNS (Portable Neuromodulation Stimula... Full story

Yahoo Finance • 6 days ago

Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain

NEWTOWN, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (the "Company" or "HSDT"), today announced its first acquisition of Solana (“SOL”) tokens as part of its digital asset treasury strategy under which the p... Full story

Yahoo Finance • 11 days ago

Forward Industries Files $4 Billion Shelf Plan To Fuel Solana Treasury Bet

Forward Industries Inc. (NASDAQ:FORD) filed an automatic shelf registration with the U.S. Securities and Exchange Commission, enabling an at-the-market (ATM) equity program worth up to $4 billion. The framework allows the company to issue... Full story

Yahoo Finance • 16 days ago

Which stocks are gapping on Friday?

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. [gap] GAP UP STOCKS TICKER CHANGE COMMENT OPI [https://w... Full story

Yahoo Finance • 2 months ago

Helius Medical stock soars after positive stroke therapy trial results

Investing.com -- Helius Medical Technologies Inc (NASDAQ:HSDT) stock surged 60% after the neurotech company announced positive outcomes from its PoNS Stroke Registrational Program, supporting a planned FDA submission for treating gait and... Full story

Yahoo Finance • 2 months ago

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced posit... Full story

Yahoo Finance • 3 months ago

Helius Medical regains compliance with Nasdaq equity listing rule

Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced it has regained compliance with the Nasdaq Capital Market’s equity listing requirement, according to a statement issued in a recent SEC filing. On Monday, the company received form... Full story

Yahoo Finance • 3 months ago

Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements

NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait def... Full story

Yahoo Finance • 3 months ago

Helius Medical Technologies files updated $25 million at-the-market offering prospectus

Helius Medical Technologies, Inc. (NASDAQ:HSDT), a medical technology company with a current market capitalization of $0.6 million, announced Monday that it has filed an updated prospectus supplement for the offer and sale of up to $25 mil... Full story

Yahoo Finance • 3 months ago

Helius Medical Technologies announces reverse stock split

* Helius Medical Technologies (NASDAQ:HSDT [https://seekingalpha.com/symbol/HSDT]) announced on Thursday a 1-for-50 reverse split of its class A common stock, effective on June 30, 2025. * Beginning on July 1, 2025, the company’s commo... Full story

Yahoo Finance • 3 months ago

Helius Medical Technologies Announces Reverse Stock Split

NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait defi... Full story

Yahoo Finance • 4 months ago

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study results expanded up... Full story

Yahoo Finance • 4 months ago

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement- -Out of Network reimbursement is only the first step towards expand... Full story

Yahoo Finance • 4 months ago

Helius Medical Technologies stock falls after pricing capital raise of $9.1M via securities offering

Helius Medical Technologies (NASDAQ:HSDT [https://seekingalpha.com/symbol/HSDT]) on Wednesday has priced its public offering, [https://seekingalpha.com/pr/20127142-helius-medical-technologies-announces-pricing-of-9_1-million-public-offerin... Full story

Yahoo Finance • 4 months ago

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait def... Full story

Yahoo Finance • 4 months ago

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

NEWTOWN, Pa., May 20, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced it will high... Full story

Yahoo Finance • 8 months ago

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis-- --Statistically significant findings in DGI (Dynamic G... Full story

Yahoo Finance • 8 months ago

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait defi... Full story

Yahoo Finance • 8 months ago

Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target

--128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January-- --The stroke registrational program is intended to demonstrate the safet... Full story

Yahoo Finance • 2 years ago

Helius Medical Technologies to Present at NobleCon19 Annual Conference

NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait defi... Full story